Skip to main navigation Skip to search Skip to main content

Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation

  • Eytan Wine*
  • , Marina Aloi
  • , Stephanie Van Biervliet
  • , Jiri Bronsky
  • , Javier Martín di Carpi
  • , Marco Gasparetto
  • , Laura Gianolio
  • , Hannah Gordon
  • , Iva Hojsak
  • , Alexandra S. Hudson
  • , Séamus Hussey
  • , Johan van Limbergen
  • , Erasmo Miele
  • , Lorenzo Norsa
  • , Ola Olén
  • , Gianluca Pellino
  • , Patrick van Rheenen
  • , Lissy de Ridder
  • , Richard K. Russell
  • , Dror S. Shouval
  • Eunice Trindade, Dan Turner, David C. Wilson, Anat Yerushalmy Feler, Amit Assa*
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Objectives: Despite advances in the management of ambulatory paediatric ulcerative colitis (UC), challenges remain as many patients are refractory to therapy and some require colectomy. The aim of these guidelines is to provide an update on optimal care for UC through detailed recommendations and practice points. Methods: These guidelines are an update to those published in 2018 and are a joint effort of the Paediatric IBD Porto group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation. An extensive literature search with subsequent evidence appraisal using the Oxford methodology was performed, followed by three online voting sessions and a consensus face-to-face meeting. Thirty-nine recommendations and 77 practice points were endorsed by the 25 experts with at least an 84% consensus rate. Results: Robust evidence-based recommendations and detailed practice points are provided. In addition to reemphasising and updating the role of more ‘traditional’ UC therapies, these guidelines outline optimising the use of antitumour necrosis factor therapies and integrating newer biologics and small molecules, as well as supportive therapy, to improve outcomes and provide an updated management algorithm. Measurement and monitoring tools and decision aids are provided, and additional aspects, including nutritional support, extraintestinal manifestations, pouchitis, inflammatory bowel disease-unclassified and patient support, are discussed. Some aspects, including surgery and thromboprophylaxis, are covered in the acute severe UC guidelines. Conclusions: These guidelines serve as an aid in managing children with UC through a combination of evidence-based recommendations and more practical practice points in the ambulatory setting.

Original languageEnglish
Pages (from-to)765-815
Number of pages51
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume81
Issue number3
DOIs
StatePublished - Sep 2025

Bibliographical note

Publisher Copyright:
© 2025 The Author(s). Journal of Pediatric Gastroenterology and Nutrition published by Wiley Periodicals LLC on behalf of European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Keywords

  • Paediatric Ulcerative Colitis Activity Index
  • biologics
  • children
  • inflammatory bowel disease-unclassified
  • thiopurines

Fingerprint

Dive into the research topics of 'Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation'. Together they form a unique fingerprint.

Cite this